Andrew Biankin
Professor
Department of Oncology
University of Glasgow
United Kingdom
Biography
Andrew Biankin is currently working as a Regius Chair of Surgery/Director of Translational Research Centre (Translational Research Centre)
Research Interest
Andrew Biankin is a surgeon-scientist whose research goals are to improve outcomes for individuals with pancreatic cancer through the development of early detection and novel therapeutic strategies based on molecular phenotyping and the delineation and implementation of biomarkers that facilitate clinical decision-making. He contributes to the International Cancer Genome Consortium through extensively characterising the genomic, transcriptomic and epigenomic aberrations in pancreatic cancer, and is extending this knowledge to a personalized model of cancer care, where molecular characteristics guide treatment decisions.
Publications
-
Johns, A. L. et al. (2017) Lost in translation: returning germline genetic results in genome-scale cancer research. Genome Medicine, 9, 41. (doi:10.1186/s13073-017-0430-4) (PMID:28454591) (PMCID:PMC5408494)
-
Feigin, M. E. et al. (2017) Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma. Nature Genetics, 49(6), pp. 825-833. (doi:10.1038/ng.3861) (PMID:28481342)
-
Harris, N.L.E. et al. (2017) SerpinB2 regulates stromal remodelling and local invasion in pancreatic cancer. Oncogene, 36(30), pp. 4288-4298. (doi:10.1038/onc.2017.63) (PMID:28346421) (PMCID:PMC5537606)
